Neurological symptoms in psoriasis patients under treatment with infliximab
| Autor: | Shooka Esmaeeli, Zahra Azizian, Amir Houshang Ehsani, Mansour Deylami, Elham Behrangi, Gholamhossein Ghaffarpour, Romina Espahbodi, Forouzandeh Sadrzadeh |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
lcsh:Arctic medicine. Tropical medicine Side effect Referral business.industry lcsh:RC955-962 Significant difference Neurological symptoms medicine.disease Biochemistry Genetics and Molecular Biology (miscellaneous) Motor symptoms Infliximab Surgery lcsh:Biology (General) Internal medicine Psoriasis medicine Drug side effects Sensory symptoms business lcsh:QH301-705.5 medicine.drug |
| Zdroj: | Asian Pacific Journal of Tropical Biomedicine, Vol 5, Iss 10, Pp 878-879 (2015) |
| ISSN: | 2221-1691 |
| Popis: | Objective To study the neurological symptoms of psoriasis patients who used infliximab. Methods We studied psoriasis patients who used infliximab in two referral general hospitals in Tehran from January 2013 to January 2014. We completed neurological symptoms checklists by questioning the patients. Results Sixty patients with psoriasis were included in this study. Among them, 3 patients had sensory symptoms as side effect and one patient showed motor symptoms as side effect. There was no statistically significant difference between age, gender, and session count with the sensory and motor side effects ( P > 0.05). Conclusions Neurological symptoms can be detected among 6% of patients under treatment with infliximab and there is no significant association between symptoms and gender, duration of drug use as well as age. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|